195 related articles for article (PubMed ID: 17652879)
1. Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease.
Saito Y; Sasaki K; Katsuda Y; Murohara T; Takeshita Y; Okazaki T; Arima K; Katsuki Y; Shintani S; Shimada T; Akashi H; Ikeda H; Imaizumi T
Circ J; 2007 Aug; 71(8):1187-92. PubMed ID: 17652879
[TBL] [Abstract][Full Text] [Related]
2. Therapeutic angiogenesis in Buerger's disease (thromboangiitis obliterans) patients with critical limb ischemia by autologous transplantation of bone marrow mononuclear cells.
Motukuru V; Suresh KR; Vivekanand V; Raj S; Girija KR
J Vasc Surg; 2008 Dec; 48(6 Suppl):53S-60S; discussion 60S. PubMed ID: 19084740
[TBL] [Abstract][Full Text] [Related]
3. Stem cell therapy for treatment of thromboangiitis obliterans (Buerger's disease).
Cacione DG; do Carmo Novaes F; Moreno DH
Cochrane Database Syst Rev; 2018 Oct; 10(10):CD012794. PubMed ID: 30378681
[TBL] [Abstract][Full Text] [Related]
4. Administration of Adult Human Bone Marrow-Derived, Cultured, Pooled, Allogeneic Mesenchymal Stromal Cells in Critical Limb Ischemia Due to Buerger's Disease: Phase II Study Report Suggests Clinical Efficacy.
Gupta PK; Krishna M; Chullikana A; Desai S; Murugesan R; Dutta S; Sarkar U; Raju R; Dhar A; Parakh R; Jeyaseelan L; Viswanathan P; Vellotare PK; Seetharam RN; Thej C; Rengasamy M; Balasubramanian S; Majumdar AS
Stem Cells Transl Med; 2017 Mar; 6(3):689-699. PubMed ID: 28297569
[TBL] [Abstract][Full Text] [Related]
5. Letter by Akar et al regarding article, "Effect of autologous bone-marrow cell transplantation on ischemic ulcer in patients with Buerger's disease".
Akar AR; Durdu S; Baran C
Circ J; 2008 Apr; 72(4):684; author reply 685-6. PubMed ID: 18362447
[No Abstract] [Full Text] [Related]
6. Autologous bone-marrow mononuclear cell implantation for patients with Rutherford grade II-III thromboangiitis obliterans.
Durdu S; Akar AR; Arat M; Sancak T; Eren NT; Ozyurda U
J Vasc Surg; 2006 Oct; 44(4):732-9. PubMed ID: 16926085
[TBL] [Abstract][Full Text] [Related]
7. Successful stem cell therapy using umbilical cord blood-derived multipotent stem cells for Buerger's disease and ischemic limb disease animal model.
Kim SW; Han H; Chae GT; Lee SH; Bo S; Yoon JH; Lee YS; Lee KS; Park HK; Kang KS
Stem Cells; 2006 Jun; 24(6):1620-6. PubMed ID: 16497946
[TBL] [Abstract][Full Text] [Related]
8. Treatment of thromboangiitis obliterans (Buerger's disease) by intramuscular gene transfer of vascular endothelial growth factor: preliminary clinical results.
Isner JM; Baumgartner I; Rauh G; Schainfeld R; Blair R; Manor O; Razvi S; Symes JF
J Vasc Surg; 1998 Dec; 28(6):964-73; discussion 73-5. PubMed ID: 9845647
[TBL] [Abstract][Full Text] [Related]
9. Early Results of Clinical Application of Autologous Whole Bone Marrow Stem Cell Transplantation for Critical Limb Ischemia with Buerger's Disease.
Heo SH; Park YS; Kang ES; Park KB; Do YS; Kang KS; Kim DI
Sci Rep; 2016 Jan; 6():19690. PubMed ID: 26791280
[TBL] [Abstract][Full Text] [Related]
10. Angiogenesis facilitated by autologous whole bone marrow stem cell transplantation for Buerger's disease.
Kim DI; Kim MJ; Joh JH; Shin SW; Do YS; Moon JY; Kim NR; Lim JE; Kim AK; Eo HS; Kim BS; Cho SW; Yang SH; Park CJ; Shim JS
Stem Cells; 2006 May; 24(5):1194-200. PubMed ID: 16439614
[TBL] [Abstract][Full Text] [Related]
11. [A clinical study on implantation of autologous bone marrow mononuclear cells after bone marrow stimulation for treatment of lower limb ischemia].
Gu Y; Zhang J; Qi L
Zhongguo Xiu Fu Chong Jian Wai Ke Za Zhi; 2006 Oct; 20(10):1017-20. PubMed ID: 17140078
[TBL] [Abstract][Full Text] [Related]
12. The Efficacy of Percutaneous Transluminal Angioplasty on the Limb Salvage and Recovery of Symptoms in Patients With Buerger's Disease With Critical Limb Ischemia.
Rodoplu O; Yildiz CE; Oztas DM; Conkbayir C; Unal O; Ulukan MO; Meric M; Ugurlucan M; Kirbas A
J Invasive Cardiol; 2020 Jun; 32(6):E158-E167. PubMed ID: 32479418
[TBL] [Abstract][Full Text] [Related]
13. Safety and efficacy of autologous progenitor cell transplantation for therapeutic angiogenesis in patients with critical limb ischemia.
Kajiguchi M; Kondo T; Izawa H; Kobayashi M; Yamamoto K; Shintani S; Numaguchi Y; Naoe T; Takamatsu J; Komori K; Murohara T
Circ J; 2007 Feb; 71(2):196-201. PubMed ID: 17251666
[TBL] [Abstract][Full Text] [Related]
14. Classification of corkscrew collaterals in thromboangiitis obliterans (Buerger's disease): relationship between corkscrew type and prevalence of ischemic ulcers.
Fujii Y; Soga J; Nakamura S; Hidaka T; Hata T; Idei N; Fujimura N; Nishioka K; Chayama K; Kihara Y; Higashi Y
Circ J; 2010 Aug; 74(8):1684-8. PubMed ID: 20534945
[TBL] [Abstract][Full Text] [Related]
15. A Multicenter Prospective Interventional Trial of Therapeutic Angiogenesis Using Bone Marrow-Derived Mononuclear Cell Implantation for Patients With Critical Limb-Threatening Ischemia Caused by Thromboangiitis Obliterans.
Fujioka A; Yanishi K; Yukawa A; Imai K; Yokota I; Fujikawa K; Yamada A; Naito A; Shoji K; Kawamata H; Higashi Y; Ishigami T; Sasaki KI; Tara S; Kuwahara K; Teramukai S; Matoba S
Circ J; 2023 Aug; 87(9):1229-1237. PubMed ID: 36908168
[TBL] [Abstract][Full Text] [Related]
16. Early outgrowth EPCs generation is reduced in patients with Buerger's disease.
Katsuki Y; Sasaki K; Toyama Y; Ohtsuka M; Koiwaya H; Nakayoshi T; Imaizumi T
Clin Res Cardiol; 2011 Jan; 100(1):21-7. PubMed ID: 20607542
[TBL] [Abstract][Full Text] [Related]
17. Implantable spinal cord stimulator to treat the ischemic manifestations of thromboangiitis obliterans (Buerger's disease).
Swigris JJ; Olin JW; Mekhail NA
J Vasc Surg; 1999 May; 29(5):928-35. PubMed ID: 10231644
[TBL] [Abstract][Full Text] [Related]
18. Sequential intravenous allogeneic mesenchymal stromal cells as a potential treatment for thromboangiitis obliterans (Buerger's disease).
Martin-Rufino JD; Lozano FS; Redondo AM; Villaron EM; Rueda R; Fernandez-Samos R; Sanchez-Guijo F
Stem Cell Res Ther; 2018 May; 9(1):150. PubMed ID: 29848379
[TBL] [Abstract][Full Text] [Related]
19. Phase IV postmarketing surveillance study shows continued efficacy and safety of Stempeucel in patients with critical limb ischemia due to Buerger's disease.
Gupta PK; Dutta S; Kala S; Nekkanti M; Desai SC; Mahapatra SS; Dhar A; Raju R; M R; Behera A; P S; Raviraja NS; Viswanathan P; Chandrashekar M; Thej C; K V P; Abraham J; Boggarapu H; Udaykumar K
Stem Cells Transl Med; 2021 Dec; 10(12):1602-1613. PubMed ID: 34519179
[TBL] [Abstract][Full Text] [Related]
20. Fate of ischemic limbs in patients with Buerger's disease based on our 30-year experience: does smoking have a definitive impact on the late loss of limbs?
Sugimoto M; Miyachi H; Morimae H; Kodama A; Narita H; Banno H; Yamamoto K; Komori K
Surg Today; 2015 Apr; 45(4):466-70. PubMed ID: 24845736
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
